Global Antiobesity Market
Pharmaceuticals

How Will The Antiobesity Market Globally Expand In 2023?

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s antiobesity market report forecasts the antiobesity market size to grow to $5.11 Billion by 2027, with a CAGR (compound annual growth rate) of more than 10%.

Learn More On The Antiobesity Market Report 2023 – https://www.thebusinessresearchcompany.com/report/antiobesity-global-market-report

Antiobesity Market Size Forecast
The global antiobesity market is expected to grow from $3.11 billion in 2022 to $3.46 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global antiobesity market size is expected to grow to $5.11 billion in 2027 at a CAGR of 10.2%.

North America held the largest antiobesity market share, and Middle East was the fastest-growing region in 2022.

Key Antiobesity Market Driver ­– Globally Rise In The Prevalence Rate Of Obesity
For instance, in May 2022, according to the World Obesity Atlas, a UK-based obesity organization, globally, it is estimated that more than 1 billion people will be suffering from obesity by 2030. This can be attributed to increased consumption of processed and unhealthy food, lack of physical activity, and lack of awareness of the risks of obesity. As a result, the demand for anti-obesity drugs is bound to increase in the future thus, driving the market growth.

Request for A Sample Of The Global Antiobesity Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3403&type=smp

Key Antiobesity Market Trend – Developing Drugs For Metabolic Disorders
The pharmaceutical industry is witnessing an increase in the number of mergers and acquisitions among companies developing drugs for metabolic disorders such as obesity, diabetes, and others. This is a strategy of pharmaceutical companies to strengthen their drug portfolio in metabolic diseases and launch safe and effective drugs in the market. For instance, Evotec AG and Novo Nordisk entered into a strategic alliance to able to discover and develop drug molecules to treat metabolic disorders including obesity, diabetes, and other associated disorders.

Antiobesity Market Segment
1) By Drug Class: Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs
2) By Type: Prescription Drugs (Rx), OTC Drugs
3) By Medication: Monotherapies, Polytherapies

Antiobesity Market Major Players and Strategies
Major players in the antiobesity market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC., BoehringerIngelheim GmbH, and Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceuticals Company Limited, Eisai Co. Ltd. and Novo Nordisk A/S.

The Antiobesity Global Market Report 2023 covers regional data on antiobesity market size, antiobesity market trends and drivers, opportunities, strategies, and antiobesity market competitor analysis. The countries covered in the antiobesity market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The anti-obesity drugs refer to the medications that are used to lower or regulate weight of a patient. These drugs interfere with one of the body’s basic functions, controlling weight, by affecting either appetite or calorie absorption. Dieting (a healthy diet and caloric restriction) and exercise continue to be the main therapeutic approaches for overweight and obese people.

View More Reports Related To The Antiobesity Market –
Antacids Global Market Report 2023
Gastrointestinal Devices Global Market Report 2023
Antidiarrhoeals Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn:
https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: